Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Gamma Biologicals' ReAct blood test system overseas launch slated for early 1996.

This article was originally published in The Gray Sheet

Executive Summary

GAMMA BIOLOGICALS' REACT GEL-BASED BLOOD TYPING TESTS will cost about 35-45 [cents] per unit compared to 16-25 [cents] for traditional methodology tests, the firm states. Although the unit cost of disposables would be higher for the ReAct tests, the firm believes the second-generation product will reduce overall lab costs due to greater ease of use and lower labor costs.
Advertisement
Advertisement
UsernamePublicRestriction

Register

MT004560

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel